We make one of these two products, so treat this as a positioned comparison rather than a neutral one. Kneat is a well-regarded paperless validation platform with a strong presence in large pharmaceutical manufacturing. GxP Copilot aims at a different part of the problem, and for a meaningful set of organisations Kneat is the better answer.
Both products agree that paper-based validation is finished. They disagree about what replaces the authoring effort.
Different starting points
Kneat's proposition is a controlled digital environment for executing validation — forms, workflow, review, electronic signature, a controlled record. It does this well and it genuinely removes the problems of paper: lost pages, illegible entries, transcription errors, the filing cabinet nobody can search.
Kneat is also adding AI. Its 26R2 release includes a Validation Summary Report agent that drafts the issue, test and executive summary sections and aggregates results across executed documents, and an AI Validation Expert that answers regulatory questions with citations, with administrators controlling where AI is used. Kneat was acquired by Thoma Bravo in August 2026 and has said it plans to expand the platform.
Most hours in a typical project still go into writing requirements, risk assessments and test scripts. That is where our approach differs. GxP Copilot drafts the package from the start and routes it to your people for review and approval. The drafting moves; the judgement and the accountability do not. GxP AI vs. manual validation goes into the comparison in more detail.
Validating its own AI
If a validation platform uses AI, it has an obligation its customers do not get to ignore: it must be able to show that its own AI is governed and evaluated. You will be the one asked about it during an inspection, not the vendor.
The questions worth asking any vendor, drawn from the draft EU GMP Annex 22 — published for consultation in July 2025, not yet in force, and still the clearest statement of direction available: what is the model approved for and what is it not, what evaluation set gates a release, what deterministic safeguards sit on outputs, how is drift monitored and what triggers a review, and what happens to the regulated workflow when the AI is switched off.
That last one is the test most AI features fail. If the workflow cannot proceed without the AI, there is no fallback, and a fallback is not optional. Annex 22 assurance is our published position and Human-in-the-Loop reviews is how the review gate is enforced in the product rather than in a procedure.
Where Kneat is the better choice
- You are already on it and it works. The cost and risk of replacing a functioning validated platform is real, and should not be taken on for a marginal improvement.
- Large-scale, multi-site execution is the core requirement. If your challenge is coordinating many people executing many protocols across sites under one controlled process, that is the problem Kneat was built for.
- Large-scale equipment and facility qualification is the core. GxP Copilot covers equipment and instrument qualification too, but Kneat has a long track record running physical IQ, OQ and PQ across large manufacturing sites, and that experience counts.
- Your organisation is not ready to put AI in the validation path. That is a legitimate governance position and we would rather you hold it honestly than adopt something you cannot defend.
Where we fit better
Mid-market pharmaceutical and biotech organisations where the binding constraint is the number of qualified people available to author documentation. Paperless execution does not relieve that; drafting does.
Organisations making a real transition to risk-based assurance under the FDA's Computer Software Assurance guidance, finalised in September 2025 and reissued in February 2026. CSA reduces effort only if test depth genuinely follows per-requirement risk and the reasoning is recorded — otherwise it becomes CSV with new paperwork. AI Risk Assessment makes the determination explicit and keeps the reasoning in the record.
And organisations that need traceability to be live. A matrix maintained by hand reports whatever it was last told. Live RTM keeps requirements, risks and evidence joined as they change, which matters most when a requirement moves late in a project.
How to decide
Take the same real system to both. A user requirements specification of your own, preferably an imperfect one. Ask each vendor to produce the same deliverables, then compare what a qualified reviewer would actually accept and how much rework was needed.
Then change a requirement and watch what happens to the traceability. That is where the difference between a controlled document environment and a maintained model becomes visible, and it is the scenario every project encounters.
book a demo if you want us to run against your own URS. the signs your validation practice is stuck is worth reading first if you are not yet sure the current approach is the problem.
Related reading
If you are building a wider shortlist, see our Kneat alternatives guide, how validation software is priced, and what is involved in switching validation platforms.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.
